Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 7, 2019
View Archived Issues
Identification of PDE10A inhibitors with potential application in schizophrenia
Read More
Phase III data demonstrates equivalence between SB8 and bevacizumab in terms of best ORR
Read More
Shanghai Fochon Pharmaceutical, Fochon Pharmaceuticals patent TRK inhibitors
Read More
Development of novel sclerostin-resistant mouse model of T1D
Read More
Symphogen presents early clinical data for Sym-015 in advanced solid tumors
Read More
Results presented from phase III SANET-ep study of surufatinib
Read More
First-in-human study of apramycin
Read More
GlaxoSmithKline initiates phase I study of GSK-2904545A vaccine candidate
Read More
CAR-iNKT cells safe and active in neuroblastoma patients
Read More
Preclinical results for IKS-01, a next-generation ADC with antitumor activity
Read More
Escalier Biosciences describes new RORgammaT modulators
Read More
Mavupharma presents E-NPP1 inhibitors
Read More
Peptide Logic awarded NIH HEAL initiative grant
Read More
New GBP1 and/or GBP1/PIM1 interaction inhibitors discovered at Stanford University
Read More
Arbutus Biopharma patents HBsAg secretion inhibitors
Read More
Keeping score by DRUP, not in dribs and drabs
Read More
Shire Human Genetic Therapies presents new kallikrein B inhibitors
Read More
Main function of Parkinson's gene is in inflammation
Read More
FDA approves Aklief cream for topical treatment of acne
Read More
GSK begins first-in-human study of rabies vaccine GSK-3903133A
Read More
Positive phase II data presented for lurbinectedin in malignant pleural mesothelioma
Read More
ReveraGen presents 18-month data on vamorolone in Duchenne muscular dystrophy
Read More
Kodiak begins phase II study of KSI-301 for wet AMD
Read More
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe